The invention discloses a cardiac pacemaker, characterized in that the cardiac pacemaker comprises a multiple of microneedles and a chip comprising at least one comparator with adaptive level, sequence control circuit, at least one capacitor stack built by n capacitors and 2n switches, at least one buffer capacitor outside the at least one capacitor stack, at least two additional switches outside the at least one capacitor stack, a CMOS-Logic, wherein further, the cardiac pacemaker comprises an interposer layer comprising holes for the multiple of microneedles and a lid. The cardiac pacemaker is characterized in that the chip, is located on one surface of the interposer layer and that the lid and the interposer layer form a capsule for the chip. Further, each microneedle of the array of microneedles has a distal end which protrudes from the chip and the cardiac pacemaker is adapted to be electrically self-sufficient.

A medical device and a manufacturing method for such medical device having an assembly comprising: an elongated solid housing with an outer surface and a maximum outer diameter, at least one electrical contact area at the outer surface of the housing, and a processor encapsulated within the housing,
wherein the method comprises the following steps: providing the assembly and a tube consisting of a plastic and electrically insulating material, wherein an inner diameter of the tube is greater than the maximum outer diameter (108) of the assembly, accommodating the assembly within the tube such that at least one electrical contact area of the assembly is not covered, and applying a shrinking step to the tube such that the shrunken tube is firmly attached to the outer surface of the housing.

The manufacturing method is cheaper and less time consuming than state-of-the-art methods, and also better suitable for automation.

A medical device and a manufacturing method for such medical device having an assembly comprising: an elongated solid housing with an outer surface and a maximum outer diameter, at least one electrical contact area at the outer surface of the housing, and a processor encapsulated within the housing,
wherein the method comprises the following steps: providing the assembly and a tube consisting of a plastic and electrically insulating material, wherein an inner diameter of the tube is greater than the maximum outer diameter (108) of the assembly, accommodating the assembly within the tube such that at least one electrical contact area of the assembly is not covered, and applying a shrinking step to the tube such that the shrunken tube is firmly attached to the outer surface of the housing.

The manufacturing method is cheaper and less time consuming than state-of-the-art methods, and also better suitable for automation.

An implantable medical device comprises a housing, a circuit board structure arranged within in the housing and comprising at least one flexible section, an electronic module comprising at least one electronic component arranged on the circuit board structure, and an energy storage device for providing electrical energy for operation of the implantable medical device. The energy storage device is a solid-state battery mounted on the circuit board structure. An energy generation device connected to the energy storage device is a secondary cell, wherein the energy generation device is configured to convert patient energy to electrical energy for charging the energy storage device.

An implantable medical device comprises a housing, a circuit board structure arranged within in the housing and comprising at least one flexible section, an electronic module comprising at least one electronic component arranged on the circuit board structure, and an energy storage device for providing electrical energy for operation of the implantable medical device. The energy storage device is a solid-state battery mounted on the circuit board structure. An energy generation device connected to the energy storage device is a secondary cell, wherein the energy generation device is configured to convert patient energy to electrical energy for charging the energy storage device.

Wirelessly powered implantable pulse generators (IPG) are described. In an embodiment, a wirelessly powered stimulator, includes an implantable pulse generator (IPG), including: an Rx antenna that receives a radio frequency (RF) signal from an external Tx antenna; a rectifier; an energy storage capacitor C.sub.STOR, where the RF signal coupled to the Rx antenna is rectified by the rectifier to generate VDD and charges the C.sub.STOR; a demodulator; an output voltage regulator that generates a stable voltage to activate the demodulator; and where the demodulator outputs a stimulation that releases the energy stored in the C.sub.STOR on an electrode based on detecting amplitude modulation in the received RF signal; and a Tx antenna that generates the RF signal that wirelessly powers the IPG and that controls timing of output stimulations of the IPG, where amplitude modulation is applied to the RF signal to control the timing of the output stimulations.

The present invention describes a system that uses ultrasonic waves to transfer energy and data, enabling for the control and recharging of a cardiac assist device. Data and energy transfer are accomplished using pulsed ultrasonic waves. The use of ultrasonic waves allows for wireless transcutaneous energy transfer to power the cardiac assist device pump in absence of a driveline, reducing complications associated with driveline infections and improving patient quality of life.

Systems and methods are disclosed in which a time series analysis algorithm is used to analyze inputs such as adjustments a patient has made to the amplitude of stimulation in an implantable stimulator system. The algorithm uses these inputs to predict how the patient would likely adjust the amplitude in the future, i.e. to predict future amplitudes for the patient as a function of time. Preferably, the algorithm determines one or more of an amplitude level, at least one seasonal variation, or at least one trend when predicting the amplitude. This predicted amplitude can then be used to automatically adjust the amplitude of the stimulation provided by the patient's stimulator. The algorithm may only use previous amplitude adjustments to predict the amplitude, other time-varying inputs, or combinations of both.

Systems and methods are disclosed in which a time series analysis algorithm is used to analyze inputs such as adjustments a patient has made to the amplitude of stimulation in an implantable stimulator system. The algorithm uses these inputs to predict how the patient would likely adjust the amplitude in the future, i.e. to predict future amplitudes for the patient as a function of time. Preferably, the algorithm determines one or more of an amplitude level, at least one seasonal variation, or at least one trend when predicting the amplitude. This predicted amplitude can then be used to automatically adjust the amplitude of the stimulation provided by the patient's stimulator. The algorithm may only use previous amplitude adjustments to predict the amplitude, other time-varying inputs, or combinations of both.

Methods, apparatuses, systems, and implementations for inductive heating of a foreign metallic implant are disclosed. A foreign metallic implant may be heated via AMF pulses to ensure that the surface of the foreign metallic implant heats in a uniform manner. As the surface temperature of the foreign metallic implant rises, acoustic signatures may be detected by acoustic sensors that may indicate that tissue may be heating to an undesirable level approaching a boiling point. Once these acoustic signatures are detected, the AMF pulses may be shut off for a time period to allow the surface temperature of the implant to cool before applying additional AMF pulses. In this manner, the surface temperature of a foreign metallic implant may be uniformly heated to a temperature adequate to treat bacterial biofilm buildup on the surface of the foreign metallic implant without damaging surrounding tissue. The AMF pulse treatment can be combined with an antibacterial/antimicrobial treatment regimen to reduce the time and/or antibacterial dosage amount needed to remove the biofilm from the metallic implant.